Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box protein B (HMGB1) is an evolutionarily conserved non-histone nuclear protein encoded by the HMGB1 gene. It plays critical roles inside cells—organizing DNA structure, regulating transcription through chromatin remodeling—and outside cells where it acts as a prototypical alarmin/DAMP. Upon cell activation or injury (such as necrosis), HMGB1 translocates from nucleus to cytoplasm then is secreted into the extracellular space where it functions like a cytokine. Extracellularly released/secreted HMGB1 triggers inflammatory responses by binding pattern recognition receptors including TLRs (notably TLR2/TLR4), amplifying innate immunity during both sterile injury and infection. Its dysregulation contributes to pathogenesis across diverse conditions such as sepsis, autoimmune diseases (e.g., rheumatoid arthritis), cardiovascular disease (e.g., atherosclerosis), cancer immunity modulation, among others. Therapeutic strategies targeting extracellular HMGB1—such as neutralizing antibodies—are under investigation for their potential benefit in controlling excessive inflammation without compromising essential homeostatic functions.
Neutralization of extracellular HMGB1 to reduce inflammation and tissue damage by blocking its interaction with receptors such as TLR2/TLR4. Modulation of immune response by interfering with DAMP signaling. Inhibition of downstream cytokine release from macrophages/monocytes.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 protein (HMGB1).